Submitted:
15 September 2025
Posted:
16 September 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
Lung Cancer Mortality Rates in the United States (U.S.) and in Virginia (V.A.), South Carolina (S.C.), and North Carolina (N.C.)
The Importance of Lung Cancer Screening in Reducing Lung Cancer Mortality Rates
Barriers to Lung Cancer Screening
2. Materials and Methods
Institutional Review Board Approval
Participant Inclusion Criteria
- Meets current USPSTF guidelines for lung cancer screening
- Adult aged 50 to 80 years
- 20 pack-year smoking history (Note: A pack-year is a way of calculating how much a person has smoked in their lifetime. One pack-year is the equivalent of smoking an average of 20 cigarettes—1 pack—per day for a year.)
- Currently smokes or has quit smoking within the past 15 years
- Identifies as Black or African American (Note: Both Hispanic/Latino and Non-Hispanic/Latino patients are eligible as long as they also identify as Black or African American [e.g., Afro-Latino]).
- Willing to complete all navigation-related study activities
- Able to understand and the willingness to sign a written informed consent document
Federally Qualified Health Center Partnerships
Virginia and Virginia Commonwealth University Massey Comprehensive Cancer Center FQHC Partner
North Carolina and University of North Carolina-Chapel Hill Lineberger Comprehensive Cancer Center FQHC Partners
South Carolina and Medical University of South Carolina Hollings Cancer Center FQHC Partner
NCI Barrier Plan Form
3. Results
4. Discussion
5. Conclusions
Abbreviations
| FQHC | Federally qualified health center |
| LCS | Lung cancer screening |
| SU2C | Stand Up 2 Cancer |
| USPSTF | U.S. Preventive Services Task Force |
| NIMHD | National Institute on Minority Health and Health Disparities Research Framework |
| NLST | National Lung Screening Trial data |
References
- American Cancer Society. Cancer Facts & Figures 2025. American Cancer Society. Accessed August 1, 2025. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2025-cancer-facts-figures.html.
- Barker AM, Wiener RS, Reisman J, Kearney L, Dones M, Fix GM. Black US military veterans respond favourably to a booklet using narratives to normalise shared decision-making. Public Health Pract (Oxf). Jun 2025;9:100606. [CrossRef]
- Jaferian S, Love T, Singh SK, Xie Y, Hill E, Ryan Wolf J. Racial and urban-rural disparities in lung cancer care: Insight from a Latent Class Growth Analysis. J Cancer Policy. Jun 2025;44:100585. [CrossRef]
- Butler DC, Petterson S, Phillips RL, Bazemore AW. Measures of social deprivation that predict health care access and need within a rational area of primary care service delivery. Health Serv Res. Apr 2013;48(2 Pt 1):539-59. [CrossRef]
- Moyer VA, Force USPST. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. Mar 4 2014;160(5):330-8. [CrossRef]
- Rivera MP, Katki HA, Tanner NT, et al. Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement. Am J Respir Crit Care Med. Oct 1 2020;202(7):e95-e112. [CrossRef]
- Korn AR, Walsh-Bailey C, Correa-Mendez M, et al. Social determinants of health and US cancer screening interventions: A systematic review. CA Cancer J Clin. Sep-Oct 2023;73(5):461-479. [CrossRef]
- Ferguson MK, Demchuk C, Wroblewski K, et al. Does Race Influence Risk Assessment and Recommendations for Lung Resection? A Randomized Trial. Ann Thorac Surg. Oct 2018;106(4):1013-1017. [CrossRef]
- Henley SJ, Anderson RN, Thomas CC, Massetti GM, Peaker B, Richardson LC. Invasive Cancer Incidence, 2004-2013, and Deaths, 2006-2015, in Nonmetropolitan and Metropolitan Counties—United States. MMWR Surveill Summ. Jul 7 2017;66(14):1-13. [CrossRef]
- Mokdad AH, Dwyer-Lindgren L, Fitzmaurice C, et al. Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014. JAMA. Jan 24 2017;317(4):388-406. [CrossRef]
- Zafar SY, Abernethy AP. Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park). Feb 2013;27(2):80-1, 149.
- Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors’ financial burden and quality of life: a prospective cohort study. J Oncol Pract. Mar 2015;11(2):145-50. [CrossRef]
- Turrini G BD, Chen L, Conmy AB, Chappel AR, De Lew N. Access to Affordable Care in Rural America: Current Trends and Key Challenges(Research Report No. HP-2021-16). Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services Accessed August 1, 2025. https://aspe.hhs.gov/sites/default/files/documents/09e40880648376a13756c59028a56bb4/rural-health-rr.pdf.
- Mitchell A, Muluneh B, Patel R, Basch E. Pharmaceutical assistance programs for cancer patients in the era of orally administered chemotherapeutics. J Oncol Pharm Pract. Sep 2018;24(6):424-432. [CrossRef]
- Spencer JC, Samuel CA, Rosenstein DL, et al. Oncology navigators’ perceptions of cancer-related financial burden and financial assistance resources. Support Care Cancer. Apr 2018;26(4):1315-1321. [CrossRef]
- Biddell CB, Spees LP, Petermann V, et al. Financial Assistance Processes and Mechanisms in Rural and Nonrural Oncology Care Settings. JCO Oncol Pract. Sep 2022;18(9):e1392-e1406. [CrossRef]
- Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med. Aug 5 2004;351(6):575-84. [CrossRef]
- Wells KJ, Battaglia TA, Dudley DJ, et al. Patient navigation: state of the art or is it science? Cancer. Oct 15 2008;113(8):1999-2010. [CrossRef]
- Sherman DE. Transforming Practices Through the Oncology Care Model: Financial Toxicity and Counseling. J Oncol Pract. Aug 2017;13(8):519-522. [CrossRef]
- Reeder-Hayes KE, Biddell CB, Manning ML, et al. Knowledge, Attitudes, and Resources of Frontline Oncology Support Personnel Regarding Financial Burden in Patients With Cancer. JCO Oncol Pract. Aug 2023;19(8):654-661. [CrossRef]
- Alvidrez J, Castille D, Laude-Sharp M, Rosario A, Tabor D. The National Institute on Minority Health and Health Disparities Research Framework. Am J Public Health. Jan 2019;109(S1):S16-S20. [CrossRef]
- Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract. Jan-Feb 1995;3(1):19-30.
- Vargas RB, Ryan GW, Jackson CA, Rodriguez R, Freeman HP. Characteristics of the original patient navigation programs to reduce disparities in the diagnosis and treatment of breast cancer. Cancer. Jul 15 2008;113(2):426-33. [CrossRef]
- Swanson GM, Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst. Dec 6 1995;87(23):1747-59. [CrossRef]
- Biddell CB, Waters AR, Angove RSM, et al. Facing financial barriers to healthcare: patient-informed adaptation of a conceptual framework for adults with a history of cancer. Front Psychol. 2023;14:1178517. [CrossRef]
- Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. Nov 2005;15(9):1277-88. [CrossRef]
- NPIdb. Federally Qualified Health Center (FQHC)—261QF0400X — South Carolina. Accessed June 7, 2025. https://npidb.org/organizations/ambulatory_health_care/federally-qualified-health-center-fqhc_261qf0400x/sc/.
- Health Resources & Services Administration. Health Center Program Uniform Data System (UDS) Data Overview. Department of Health & Human Services. August 1, 2025. https://data.hrsa.gov/tools/data-reporting/program-data?grantNum=H80CS00293.
- NCDHHS Division of Public Health. NC State Center for Health Statistics. SCHS: Cancer Incidence Data Visualization Tools. Cancer Incidence Rates by County NC Department of Health and Human Services. Accessed August 1, 2025. https://schs.dph.ncdhhs.gov/data/cancer/county_yearly_incidence.html.
- NCIOM. North Carolina Health Data. North Carolina Institute of Medicine (NCIOM). Accessed August 1, 2025. https://nciom.org/nc-health-data/.
- Crossing the Quality Chasm: A New Health System for the 21st Century. 2001.
- Lee SJC, Lee J, Zhu H, et al. Assessing Barriers and Facilitators to Lung Cancer Screening: Initial Findings from a Patient Navigation Intervention. Popul Health Manag. Jun 2023;26(3):177-184. [CrossRef]
- Bhalla S, Natchimuthu V, Lee JL, et al. Effect of Patient Navigation on Completion of Lung Cancer Screening in Vulnerable Populations. J Natl Compr Canc Netw. Mar 15 2024;22(3):151-157. [CrossRef]



| Module 1: Research 101 | Objectives
|
| Module 1.2: Overview of Health Disparities in Lung Cancer Screening and Treatment | Objectives
|
| Module 2: Patient Navigators: Roles and Responsibilities | Objectives
|
| Module 3: Overcoming Barriers to Care | Objectives
|
| Module 4: Health Literacy | Objectives
|
| Module 5: Communication Exercise Tool | Objectives
|
| Module 5.1: Effective Communication | Objective
|
| Module 5.2: Communication and Patient Navigation | Objectives
|
| Module 6: Developing Cultural Competency/ Cultural Humility in Cance Clinical Trials Research | Objectives
|
| Module 6.1: Developing Cultural Humility in Health Care | Objectives
|
| Individual | Economic |
|
|
| Organizational | Sociocultural |
|
|
| Characteristic | SU2C Cohort Aim 1 (N=170) |
NLST LDCT Arm (N=26,723) |
|---|---|---|
| Age Group, years | ||
| 50-54 | 7.65% | 0.01% |
| 55-64 | 44.12% | 73.38% |
| 65-74 | 34.70% | 26.60% |
| 75-79 | 8.82% | 0.00% |
| Missing | 4.71% | 0.00% |
| Sex | ||
| Female | 37.06% | 40.99% |
| Male | 62.94% | 59.01% |
| Race | ||
| Black | 100.00% | 4.48% |
| Marital status | ||
| Married / living with partner | 15.29% | 66.67% |
| Divorced | 11.18% | 19.44% |
| Separated | 5.29% | 1.26% |
| Widowed | 11.76% | 7.43% |
| Single | 30.59% | 4.70% |
| Don’t know/unsure | 25.89 | 0.00% |
| Education | ||
| Less than high school | 40.00% | n/a |
| High school or GED | 25.29% | 6.14% |
| Some College / Associates degree | 18.82% | 23.48% |
| Bachelor degree | 5.89% | 14.10% |
| Don’t know/unsure | 10.00% | 0.00% |
| Smoking status | 23.43% | |
| Current | 83.53% | 16.86% |
| Former | 16.47% | 14.70% |
| Among those who quit, time (years) since quit smoking | ||
| Within 4 years | 6.47% | 14.76% |
| 4-9.9 years | 4.11% | 17.21% |
| 10-15 years | 3.53% | 19.67% |
| Missing | 2.35% | 0.21% |
| Median pack years | 28 | 48 |
| Common Reasons for Declining Participation | Common Concerns/Obstacles to Engaging in Lung Cancer Screening | Satisfaction with the Multimodal Navigation Approach |
|
|
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).